Puzzling Over the Hurt Down-Under
Serious Mental Illness and Contraception
New 13-Cycle Vaginal Contraceptive System
The Future of Family Planning in Post-COVID America
New ASCCP Guidelines: Implications for FP
On the alert: mood disorders during 2020 stressors
Challenges old and new during the pandemic
Reproductive health in the time of Covid-19
Missed Pills: The Problem That Hasn’t Gone Away
Find the “yes! . . . and” rather than “no” or “but”
Digital Family Planning: the Future is Now
Irregular Bleeding Due to Contraceptives
Ouch! Best approaches to menstrual pain
Contraceptive efficacy: understanding how user and method characteristics play their part
Strategizing treatment for chronic heavy menstrual bleeding
Untangling the literature on obesity and contraception
High tech apps for no-tech FABM
Menstrual exacerbation of other medical conditions
From Princeton University: Thomas James Trussell (1949-2018)
The Short and Long of IUD Use Duration
Selecting a Method When Guidance Isn’t Clear-cut
Healthcare in the Time of Digital Expansion
The Scoop on Two New FDA-Approved Contraceptive Methods
Pregnancy of unknown location—meeting the challenge
Big “yes” (with caveats) to CHCs during perimenopause
The role of IUDs (LNG IUDs, too!) in emergency contraception
Combined pills’ effect on mood disorders
Abortion in the U.S.: safe, declining, and under threat
Hope for ovarian cancer screening test
Breast cancer still a small risk with some hormonal contraceptives
Record rate of HPV-related throat cancer
Viruses in semen potentially transmissible
Don’t Abstain from Your Role in Abstinence
Teens births declining but geographic ‘hotspots’ defy trend
Online Medical Abortion Service Effective and Safe
Do Women Really Need to Wait That Long?
Reassuring news on depression and OC use
PMDD: Genetic clues may lead to improved treatment
Breast cancer risk when there is a family history
Body weight link to breast and endometrial cancers (and 11 others)
Family Planning in 2017 and Beyond
Make Me Cry: Depression Link (Again)?
Managing implant users’ bleeding and spotting
Zika: Updated guidance for providers
Pharmacist-prescribed contraceptives
Hot off the press! 2016 MEC and SPR
Zika virus fears prompt increased request for abortion in nations outlawing abortions
Opioid use epidemic among reproductive-age women
Good news on the family planning home front!
War Against Planned Parenthood Hurts Women
Win-win for both treatment and prevention
Menopause, mood, mental acuity, and hormone therapy
Emergency contraception for teens
Postpartum Contraception: Now, Not Later
Are we practicing what we preach?
Be alert to VTE in hormonal contraceptive users
LARC among teens increased 15-fold, but not enough
Brain cancer and hormonal contraception
Free tools: Easy access to the US Medical Eligibility Criteria for Contraceptive Use
Alcohol consumption when pregnancy is unwanted or unintended
Latest Data on Contraceptive Use in the United States
LateBreaker sampler from Contraceptive Technology conference
Emergency Contraceptive Pill Efficacy and BMI/Body Weight
Handout on Unintended Pregnancy and Contraceptive Choice
Ask About Withdrawal (Really!)
Rules to Practice By: Safety First and Cleanliness is Close to. . .
What’s Vanity Fair Got Against the NuvaRing?
Promising New Treatment for Hepatitis C
Numbers matter, so make them simple for patients
The Recession’s Effect on Unintended Pregnancies
Lessons Learned from the Contraceptive CHOICE Project: The Hull LARC Initiative
Applying the “New” Cervical Cytology Guidelines in Your Practice
Acute Excessive Uterine Bleeding: New Management Strategies
Medical indications for IUD use in teens

Across the Americas, as many as 4 million persons may become infected with Zika virus by early 2017, according to World Health Organization estimates. Most infections will occur outside of North America, where abortion is generally illegal, even for women infected during their pregnancies.
In response to the Zika virus epidemic, Latin American pregnant women who have no access to legal abortion increasingly turned to an online portal offering medication abortion, reports a study published in The New England Journal of Medicine.[1] The researchers analyzed the trend of requests, finding an increase of 36% to 108% over requests made over the 5 years before advisories alerted women of the dangers of Zika virus during pregnancy.[2] (On June 30, 2016, PAHO published an update stating that 40 countries and territories have confirmed local, vectorial transmission of Zika virus disease in the Region of the Americas since 2015.[3]) The requests were made the online service called Women on Web, a non-profit organization through which physicians prescribe pills such as mifepristone and misoprostol to women early in their pregnancies who live in areas where safe abortion is unavailable.
The researchers compared the trends within a control group, with no expected increase in requests, to the three study groups with legal restrictions on abortion:
Zika outbreak in country? | Health advisory issued? | |
A |
YES |
YES |
B |
NO |
NO |
C |
YES |
NO |
In the three control-group nations—Chile, Poland, and Uruguay—the researchers found no increase in the number of online requests for abortion pills, indicating that there appeared to be no global increase in requests for reasons other than Zika. The women in study group A increased their number of requests by more than 100% in Brazil and Ecuador, by nearly 50% in Costa Rica and Venzuela, and by a smaller but still statistically significant degree in other nations that had an ongoing Zika virus outbreak and an issued health advisory. The women in study group B showed small increases in requests from Argentina and Peru, and the women in study group C showed no difference in the number of requests. Although the researchers could not directly link Zika-related concerns to the increased demand for abortion pills, the percentage of women reporting Zika fears correlated with the country-specific increases in requests.
What about your patients, here in the United States? No cases of US-acquired mosquito-borne cases have been reported, though cases have been reported in Puerto Rico, the US Virgin Islands, and American Samoa.[4] The U..S Zika pregnancy registry reports that 7 babies born in the United States who were infected outside the United States have been born with microcephaly or other related birth defects. The CDC is monitoring another 287 pregnant women with laboratory evidence of Zika infection.[5] CDC has issued travel notices for pregnant women planning to go to Central and South America and the Carribbean and Pacific Islands.[6] Infection with Zika virus tends to be mild, requiring no specific treatment. For pregnant women, however, the risk is to their fetuses. Unfortunately, the CDC reports that we do not know the likelihood of infection upon a woman’s exposure to the virus.[7] We also do not know the likelihood of the infection passing to an infected woman’s fetus or, if the fetus does become infected, the likelihood of microcephaly or other birth defects. We also do not know if sexually transmitted Zika infection acts differently than mosquito-borne infection. Currently, no vaccine can prevent infection in the fetus or prevent a consequent microcephalic condition.
“As Zika spreads to the United States, women in the states most likely to be hardest hit, including Texas, Florida and Mississippi, face a situation that may not be so different from that of women in Brazil, Venezuela and Ecuador. Abortion access in these U.S. states has been seriously curtailed after a wave of legislation designed to close clinics,” Abigail Aiken, the lead author of the report and assistant professor at the University of Texas at Austin, wrote in the Dallas Morning News.[8] She called upon health organizations and governments to provide timely and accurate information about the risks of Zika in pregnancy and to support access to safe, legal abortions for women who want them.
[1] Aiken ARA, Gomperts R, Trussell J, Worrell M. requests for abortion in Latin America related to concern about Zika Virus exposure. Letter. N Engl J Med, June 22, 2016. DOI: http://dx.doi.org/10.1056/NEJMc1605389
[2] Pan American Health Organization, World Health Organization Regional Office for the Americas. Epidemiological alert: increase of microcephaly in the northeast of Brazil. November 17, 2015 (http://www .paho .org/ hq/index .php?option=com_docman&task=doc_view&itemid=270&gid=32285)
[3] Pan American Health Organization, World Health Organization. Regional Zika epidemiological update (Americas) – 30 June 2016. At http://www.paho.org/hq/index.php?option=com_content&view=article&id=11599:regional-zika-epidemiological-update-americas&Itemid=41691&lang=en. [Accessed July 1, 2016.]
[4] Centers for Disease Control and Prevention. Areas with Zika. At http://www.cdc.gov/zika/geo/. [Accesssed on June 30, 2016.]
[5] Berkrot B. More U.S. babies with Zika-related birth defects reported by health agency. Reuters, June 30, 2016. At http://www.reuters.com/article/us-health-zika-birthdefects-idUSKCN0ZG2PW. [Accessed June 30, 2016.]
[6] Centers for Disease Control and Prevention. Zika travel information. At https://wwwnc.cdc.gov/travel/page/zika-travel-information. [Accessed on June 29, 2016.]
[7] Centers for Disease Control and Prevention. Zika and pregnancy. http://www.cdc.gov/zika/pregnancy/question-answers.html. [Accessed on June 29, 2016.]
[8] Aiken A, Aiken C. We’re failing women amid the Zika crisis. The Dallas Morning News. July 1, 2016. At http://www.dallasnews.com/opinion/latest-columns/20160628-abigail-aiken-and-catherine-aiken-were-failing-women-amid-the-zika-crisis.ece. [Accessed July 1, 2016.]